Journal profile · PHARMACOLOGY & PHARMACY
Pharmacophore
ISSN 2229-5402
Pharmacophore: hybrid open access; 67 articles in 2025; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, Pharmacophore's largest topics are Computational Drug Discovery Methods, Machine Learning in Materials Science and Advanced Drug Delivery Systems, together about 39.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Computational Drug Discovery MethodsComputer Science24.3%
- Machine Learning in Materials ScienceMaterials Science7.8%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.1%
- Medicinal Plant ResearchAgricultural and Biological Sciences6.9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.7%
- Artificial Intelligence in Healthcare and EducationMedicine4.7%
- Biomedical Text Mining and OntologiesBiochemistry, Genetics and Molecular Biology3.1%
- Analytical Methods in PharmaceuticalsChemistry2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
Early warning / risk: Removed from ESCI for editorial reasons on 20 March 2024. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- h-index
- 15OpenAlex ·
- i10-index
- 33OpenAlex ·
- 2-year mean citedness
- 1.24OpenAlex ·
- Share of gold OA articles
- 12.24%LetPub ·
- Articles per year
- 90LetPub ·
Articles by year OpenAlex count · 493 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 55 | 55 | 223 |
| 2025 | 67 | 67 | 338 |
| 2024 | 69 | 69 | 301 |
| 2023 | 84 | 84 | 423 |
| 2022 | 93 | 38 | 104 |
| 2021 | 101 | 22 | 18 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Before you submit
Three checks before submitting to Pharmacophore
- 1ScopeRecent output centres on Computational Drug Discovery Methods, Machine Learning in Materials Science.Check scope
- 2Article type and formatPrepare text, figures and references as the author guidelines ask.
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
The checks are built from this page's data.
Profile
Publication details and official links
- ISSN
- 2229-5402
FAQ
Frequently asked questions about Pharmacophore
Is Pharmacophore open access, and what is the APC?
Pharmacophore is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .